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ABSTRACT 
Background: Premenstrual syndrome (PMS) has a worldwide pooled prevalence of 
47.8% and impacts on social and professional activities. 
Objectives: The aim of this study was to conduct a systematic review to determine the 
therapeutic effects of the homeopathic treatment on PMS.  
Methods: Various electronic database searches were conducted to identify studies 
conducted using homeopathic treatment for the treatment of PMS. Studies had to be in 
English and conducted between 1996-2015. Study designs included: Randomised 
Control Trials (RCTs), case studies and observational studies. RCTs were evaluated 
using the Checklist for Measuring Study Quality while the rest of the designs were 
evaluated using the Quality Assessment Tool for Studies of Diverse Designs. 
Results: 63 studies were identified of which only seven met the inclusion criteria. Three 
of the studies were RCTs while the rest were case studies and observational studies. Of 
the seven articles reviewed, four articles were ranked “Good”, two were ranked “Fair” 
and one was ranked “Poor”. There was a good quality article which did not support the 
hypothesis that homeopathy is effective in the treatment of PMS. Of the remaining six 
articles there are three good quality articles, two fair quality articles and one poor quality 
article which all support the hypothesis that homeopathy is effective in the treatment of 
PMS. 
Conclusion: The outcomes of this study indicate that the current available evidence on 
the therapeutic effects of the homeopathic treatment of PMS cannot contribute to 
Evidence Based Medicine. 
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1. INTRODUCTION 
Premenstrual syndrome (PMS) also known as premenstrual tension (PMT) is a disorder 
which occurs during the luteal phase of menses and is alleviated at the onset of 
menses. Symptoms may either be behavioural, mental or physical and may include, but 
are not limited to: bloating, insomnia, headaches, breast tenderness, anxiety and 
depression [1]. A study which evaluated the prevalence of PMS worldwide established 
that the pooled prevalence was 47.8%. Women suffering from PMS report withdrawal 
from social and professional activities as a result. In adolescents, school tasks and 
social activities are affected negatively [2,3,4].  
 
Conventional treatment of PMS includes using various oral contraceptive pills, Selective 
Serotonin Reuptake Inhibitors (SSRIs) or even surgery but these have been shown to 
have side-effects such as nausea, fatigue, insomnia and sexual dysfunction [5]. 
Homeopathic treatment of premenstrual syndrome may be individualised, where a 
remedy is prescribed based on the symptoms the patient experiences, or a complex 
remedy which consists of multiple remedies indicated for various symptoms of PMS is 
prescribed. Homeopathic treatment has been proven to be safe and adverse effects are 
unlikely [6,7].  
 
A systematic review of the alternate and complementary therapies on PMS was 
conducted in 2001 but only included randomised control trials. There have been various 
research designs used for the homeopathic treatment of premenstrual syndrome and 
not all of these have been subjected to a systematic review; furthermore studies on the 
homeopathic treatment of PMS have been conducted after 2001 which consequently 
warrants an updated review [8]. The aim of this study was to conduct a systematic 
review to determine the therapeutic effects of the homeopathic treatment on PMS.  
 
2. MATERIAL AND METHODS 
2.1 Selection Criteria 
In order to be included for this review, articles had to be available electronically. The 
inclusion criteria for articles were:   
 Citations had to be in electronic format 
 Citations could have been grey literature or published in peer-reviewed journals  
 Citations had to include the following words: “homeopathy” or “homeopathic”, and 
either, “premenstrual syndrome,” “premenstrual tension,” “PMT” or “PMS”. 
Various spellings of words were taken into account.  
 Articles had to be in English 
 Articles had to be RCTs, Non-RCTs, case studies, observational studies or 
mixed-method studies 
 Articles had to have been published between the years 1996-2015 
 
Articles were excluded if they were duplicate studies; books or book sections; studies 
that did not make reference to homeopathic treatment of PMS and studies published 
earlier than the year 1996 or later than the year 2015.  
The following databases were searched for any articles which met the inclusion criteria: 
EBSCOhost, CORE-Hom, Science Direct, Google Scholar, Cochrane Library, PubMed, 
AMED, CINAHL, MEDLINE, SAGE journals, Springer Link, Oxford Journals Online, 
Cambridge Journals, Scopus, UJoogle, WorldCat, OpenGrey, WorldWideScience.org, 
Nexus Database System and CDC Stacks. UJoogle and CDC Stacks were 
subsequently excluded from the database search due to technical errors arising from 
the database. 
 
A total of 2 541 articles were identified from the 18 databases that were searched using 
Boolean search strategies to obtain  English articles relating to homeopathy and PMS 
dated between 1996-2015. From those articles 2 478 were either duplicates or did not 
meet the inclusion criteria. The remaining 63 articles which did meet the inclusion 
criteria were then screened using their titles and abstracts. In the secondary search, the 
search of references of articles which passed the second screening, 21 records were 
identified of which 20 were excluded due to duplication. Screening of articles occurred 
twice in order to prevent selection bias. Figure 1 is a flow-diagram which represents the 
entire selection process of articles included for review.  
 
 
Figure 1: Flow diagram of selection process 
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Articles were screened initially using the title and abstract. This process removed 
articles which did not meet the inclusion and exclusion criteria as per the information 
stated in the title and abstract. After the first screening 35 records were excluded 
because they did not meet the inclusion criteria and 16 duplicates were removed. A 
second screening of the full-text of articles ensured that articles which had passed the 
first screening were still eligible to be a part of the review. After the second screening 
six articles were excluded for the following reasons (n=1: Original dissertation of 
published article; n=2: Intervention was not homeopathically prepared; n=1: Oral 
presentation of original article; n=1: Article not available electronically; n=1: Feasibility 
study). A further four articles could not be evaluated using the Checklist for Measuring 
Study Quality (CMSQ) by Downs & Black [9] resulting in the Quality Assessment Tool 
for Studies of Diverse Designs (QATSDD) by Sirriyeh et al. [10] being procured and 
used to evaluate the studies in question. The article obtained from the secondary 
search also underwent screening and had to be excluded due to the intervention not 
being homeopathically prepared. From the 13 articles assessed seven were finally 
included for this review: three were evaluated using the CMSQ and four were evaluated 
using the QATSDD.   
 
2.2 Data Evaluation 
Data was evaluated separately for quantitative studies and quantitative-qualitative 
studies. Quantitative studies were assessed using the CMSQ which is a valid and 
reliable tool which can be used to assess the quality of both, randomised and non-
randomised control trials. There are a total of 27 items which are broken down into 5 
sections [9].   
The 5 sections respectively are: 
 Reporting: Assesses the overall quality of the study (10 items).  
 External validity: Assesses how generalizable the results of the study are (3 
items). 
 Bias: Assesses any bias in the interventions and outcomes (7 items). 
 Selection bias: Assesses any bias found within the sampling (6 items).  
 Power: Assesses whether the findings may be due to chance (1 item) [11].  
 
Mixed-method studies were evaluated using the QATSDD which is a 16-point checklist 
which scores items on a 4-point scale. All the items on the checklist can be used to 
evaluate mixed-method designs of which there are two points which cannot be used in 
qualitative designs and two points which cannot be used in quantitative designs [12]. 
The QATSDD evaluates the following criteria: use of theory; appropriateness of study 
design; methods of data collection; rigour of reporting; sample size; outcome measures; 
analytical strategy; user involvement; critical analysis [13]. These criteria were grouped 
in the same sections as the CMSQ in order to allow for comparability between the  
studies. 
 
2.3 Ethics  
The screening of articles for inclusion and exclusion criteria was done twice, once using 
the title and abstract, and the second time confirming the criteria. This ensures that 
there is no selection bias by the researcher. The researcher kept a record of all studies 
included and excluded to prevent plagiarism and ensure duplicate studies were 
excluded. Grey literature was included in the review in order to prevent any reporting 
bias. Information of the studies was extracted and interpreted by the researcher in a 
way that was identical to the original study. Literature was cited in an accurate manner 
to appropriately acknowledge authors. This review received ethical clearance from the 
University of Johannesburg’s Research Ethics Committee. 
  
3. RESULTS 
3.1 Study Characteristics  
There were seven studies subjected to review of which three were purely quantitative 
and were RCTs (Laister, 2008 [14]; Yakir et al., 2001 [15]; Woodcock, 1998 [16]), four 
were qualitative-quantitative and used an observational study approach (Danno et al., 
2012 [17] ; Komar et al., 2006 [18]; Mudzanani, 2011 [19]; Patel, 2010 [20]). Out of the 
seven studies five were conducted in South Africa. Table 1 summarises the 
characteristics of each study.  
Author 
(year) 
Country Study Design N 
(Interventio
n/ control) 
Inclusion criteria Intervention Form of 
measurement 
Frequency of 
measurement  
Duration of study Statistical Outcomes 
Laister 
(2008) 
South Africa RCT 27 (13/14)  Females between 
18-40 
 Literate in English 
 Fulfil the 
diagnostic criteria 
for PMS 
 Experiencing 
symptoms 2-14 
days before the 
onset of menses 
Homeopathic simillimum 
or placebo 
Moos Menstrual 
Distress 
Questionnaire 
(MDQ) 
After every 
menstrual cycle  
3 menstrual cycles Water retention and 
appetite changes 
decreased significantly 
in the intervention group 
 
Inter-group analyses 
reported no significant 
differences 
Woodcock 
(1998) 
South Africa RCT 15 (5/5/5)  Participants had 
to be between 
ages 19-26 
 Had to fit the 
diagnostic criteria 
of PMS 
Vitex agnus castus 
mother tincture, Vitex 
agnus castus 3X or 
placebo 
PMS Chart Daily for five 
months 
Five months- 2 
months prior to 
treatment to 
establish whether 
symptoms are 
related to PMS 
and 3 months of 
treatment 
Participants who 
received the Vitex agnus 
castus 3X showed an 
overall improvement 
compared to the placebo 
group. 
Participants who 
received Vitex agnus 
castus mother tincture 
did not show a 
statistically significant 
overall improvement. 
Yakir et al. 
(2001) 
Israel  RCT 23 (13/10)  Participants had 
to be between 20-
50 
 Had to fit the 
diagnostic criteria 
of PMS 
 Symptomatology 
corresponding to 
one of five 
homeopathic 
drugs 
Homeopathic simillimum 
or placebo 
Daily MDQ Daily for 5 
months 
5 months: 
2 months to 
determine a 
baseline for 
symptoms and 3 
months of 
treatment 
Mean MDQ scores were 
compared between 
groups. The difference 
between the groups fell 
short of statistical 
significance.  
In 90% of women in the 
homeopathic treatment 
group there was a > 
30% improvement. In 
37.5% of women in the 
control group there was 
a > 30% improvement.   
Danno et al. 
(2012) 
France Observational 
study 
23  Symptoms had to 
be present for >3 
months 
 Homeopathic 
treatment was 
prescribed  
Homeopathic simillimum Scale Rating for 10 
clinical symptoms of 
PMS 
Quality of Life 
assessments 
At inclusion and 
follow up (3-6 
months after 
initial 
consultation) 
3-6 months  All symptoms except 
back pain showed 
statistically significant 
improvements between 
inclusion and follow-up 
consultations 
Komar et al. 
(2006) 
South Africa Observational 
study 
11  Participants had 
to comply with the 
diagnostic criteria 
for PMS 
 Females between 
Homeopathic simillimum PMS chart and full 
case history 
PMS Chart 
graded daily; 
Follow-ups were 
conducted every 
4 weeks for 16 
weeks 
4 menstrual 
cycles: 
1 menstrual cycle 
of no treatment 
and 3 menstrual 
cycles of treatment 
The homeopathic 
intervention was 
statistically effective in 
reducing the following 
symptoms of PMS: 
irritability, depression, 
18-45 breast swelling, 
abdominal bloating and 
food cravings. 
Mudzanani 
(2011) 
South Africa Observational 
study 
10  Black females 
between the ages 
of 18-40 
 An increase in 
symptoms of PMS 
one to ten days 
before menses 
and alleviation 
within the first 
three days of 
menses 
Homeopathic similimum PMS Chart, Full 
case history 
PMS Chart 
graded daily; 
Follow-ups were 
conducted every 
4 weeks for 16 
weeks 
16 weeks of which 
4 weeks were 
used to determine 
baseline of 
symptoms. 
The homeopathic 
similimum effectively 
reduced PMS symptoms 
of irritability, anxiety, 
breast tenderness and 
food cravings in month 
two and three of 
treatment.  
PMS symptoms of 
breast swelling, 
abdominal bloating and 
headaches were only 
reduced in month three 
of treatment. 
An initial aggravation in 
the first month of 
treatment occurred with 
PMS symptoms of 
premenstrual irritability 
and premenstrual 
depression. The 
researcher explained 
this as a homeopathic 
aggravation. 
Premenstrual 
depression further 
improved in the second 
and third month of 
treatment but the 
improvement was not 
statistically significant. 
Individual participant 
progress was also 
measured and 
evaluated. 
Patel (2010) South Africa Observational 
study 
10  White females 
between the ages 
of 18-40 
 An increase in 
symptoms of PMS 
one to ten days 
before menses 
and alleviation 
within the first 
three days of 
menses 
Homeopathic simillimum PMS Chart; Full 
case history 
PMS Chart 
graded daily; 
Follow-ups were 
conducted every 
4 weeks for 16 
weeks 
16 weeks of which 
4 weeks were 
used to determine 
baseline of 
symptoms. 
All 8 symptoms 
evaluated improved 
significantly from month 
0- month 3 of treatment. 
Table 1: Study characteristics for included articles 
 
3.2 Quality Assessment  
4.2.1 Checklist for Measuring Study Quality (CMSQ) 
The CMSQ was used to evaluate the purely quantitative studies yielded from the 
search. Studies were ranked according to the total score which they receive on the 
CMSQ checklist: excellent (>26), good (20-25), fair (15-20) and poor (<14). 
Table 2 and 3 depict the ranking and section scores for articles scored using the CMSQ.  
 
Article 
Number: 
Author (year) Rank Total scores 
(percentage) 
Section percentages 
1. Laister (2008) Good 21/31 (67%) Reporting: 100% 
External validity: 0% 
Internal validity – Bias: 
71% 
Internal validity - 
selection bias: 67%  
Power: 20% 
2. Woodcock 
(1998) 
Fair 15/31 (48%) Reporting: 55% 
External validity: 0% 
Internal validity – Bias: 
86% 
Internal validity - 
selection bias: 50%  
Power: 0% 
3. Yakir et al. 
(2001) 
Good 24/31 (77%) Reporting: 82% 
External validity: 33% 
Internal validity – Bias: 
86% 
Internal validity - 
selection bias: 100%  
Power: 40% 
 
Table 2: Summary of CMSQ ranking and scores  
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Table 3: CMSQ scoring for individual studies 
 
4.2.2. Quality Assessment for Studies of Diverse Designs (QATSDD) 
The QATSDD has 16 points which are scored on a scale where 0 = not at all; 1 = very 
slightly; 2 = moderately; 3 = complete. The final score from the QATSDD was given a 
corresponding grading which correlated with the grading of the CMSQ: excellent (>40), 
good (31-39), fair (23-30) and poor (<23). Table 4 and 5 depict the ranking and section 
scores for articles scored using the CMSQ. 
 
Article 
Number 
Author (year) Rank Total scores 
(percentage) 
Section percentages 
4. Danno et al. 
(2012) 
Fair 58% Reporting: 89% 
External validity: 83% 
Internal validity: 50% 
Power: 0% 
5. Komar et al. 
(2006) 
Poor 35% Reporting: 83% 
External validity: 33% 
Internal validity: 33% 
Power: 0% 
6. Mudzanani 
(2011) 
Good 73% Reporting: 100% 
External validity: 83% 
Internal validity: 70% 
Power: 0% 
7. Patel (2010) Good 67% Reporting: 100% 
External validity: 50% 
Internal validity: 67% 
Power: 0% 
 
Table 3: Summary of QATSDD ranking and scores 
  
 Table 4: CMSQ scoring for individual studies 
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 4. DISCUSSION  
Of the seven articles reviewed, four articles were ranked “Good”, two were ranked “Fair” 
and one was ranked “Poor”. Article 3 was a good quality article which did not support 
the hypothesis that homeopathy is effective in the treatment of PMS. Of the remaining 
six articles there are three good quality articles, two fair quality articles and one poor 
quality article which all support the hypothesis that homeopathy is effective in the 
treatment of PMS. Table 5 summarises which articles supported homeopathic treatment 
for PMS and what their quality ranking is.  
 
 
Article Supports homeopathic 
treatment for PMS? 
Quality Ranking 
Article 1 No Good 
Article 2 Yes Fair 
Article 3 Yes Good 
Article 4 Yes Fair 
Article 5 Yes Poor 
Article 6 Yes Good 
Article 7  Yes Good 
 
Table 5: Article Quality and Conclusion in Relation to Quality Ranking 
 
Scores were discussed according to the sections evaluated in order to determine 
commonalities between articles. Figure 2 demonstrates the breakdown of the scores for 
each of the articles. 
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Figure 2: Graphical representation of section scores 
 
Articles displayed Good Qualities of Reporting with Article 2 being the only study to 
have sub-standard reporting skills despite being an original dissertation. The original 
dissertations had greater than average reporting skills as compared to published articles 
which lacked some information since published articles are usually summarised to 
contain concise and relevant information.  
 
Internal Validity of articles 1-3 as well as articles 6 and 7 were above average. All the 
studies evaluated using the CMSQ were RCTs and both assessors and participants 
were blinded. All of the studies used valid measurement tools however not every study 
mentioned the reliability and validity of the measurement tool. All the studies used some 
sort of MDQ where symptoms of PMS were evaluated on a scale. Articles 1 and 4 only 
evaluated symptoms at follow-up consultations while the rest of the articles asked 
participants to evaluate their symptoms daily, ensuring more detailed data with 
increased information available for analysis. Statistical analyses were conducted in 
each study however it is imperative that the statistical tests used are correct in order to 
correctly interpret data. Articles 2 and 5 did not use the correct statistical tests to 
interpret their data Article 1 could have performed further statistical tests. By not using 
correct statistical tests the conclusions made from those studies need to be overlooked.  
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The external validity of studies is important as it relates to how generalizable the study 
is and to what extent the results can be extrapolated. Article 5 and 7 did not have clear 
research settings which makes it difficult to determine what the source population of 
participants are and whether the sample is representative of the source population.  
 
The final and most pertinent point is the power of the articles. The power of an article 
directly determines the likelihood of outcomes being due to chance. The power of an 
article is responsible for ensuring that the null hypothesis is correctly rejected and 
prevents Type II errors (accepting the null hypothesis incorrectly). The significance level 
(α), is responsible for ensuring that a Type I error does not occur. A Type I error is when 
a true null hypothesis is rejected incorrectly. The significance level is important in 
deciding whether tests are statistically significant and the P-value is the name given to 
the smallest significance level that would reject the null hypothesis [21]. The power of 
the study is important for researchers in order to determine what sample size is required 
to have a good chance in determining the effect the researchers require [22]. All the 
studies evaluated have quite small sample sizes, which directly affect the chances of 
having a statistically significant result using a small effect size.  
 
Small sample sizes are a direct effect of the lack of funding which affects homeopathic 
research. Article 7 notes that financial constraints was a limiting factor for the sample 
size and in the discussion recommended that further studies with larger sample sizes 
need to be conducted. International homeopathic research is mainly funded by 
associations which rely on private funding [23]. However, in South Africa the Masters 
qualification in Homoeopathy provides an allocated amount per student to be able to 
complete the qualification. This amount, however, is insufficient to conduct large-scale 
studies and the students themselves lack the experience to produce high quality clinical 
trials.  
 
The CMSQ evaluated studies to see whether they have statistical power. Article 1 
scored 20% and Article 3 scored 40% and for this question. Article 2 was also assessed 
but with a sample size of 15 split into three intervention groups the study did not have 
any statistical power. The QATSDD assessed whether articles showed statistical 
considerations in determining a sample size. Three of the studies assessed with the 
QATSDD had sample sizes of between 10-11 participants while only one had a sample 
of 23 participants. None of the studies showed any statistical considerations in 
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determining a sample size and this is problematic as results have small significance 
levels making Type I errors rare but Type II errors could transpire.  
 
Upon further investigation, it was noted that all the studies used non-parametric 
statistical tests for data analyses. Non-parametric tests are used when the assumption 
that the data is not normally distributed is made. One “disadvantage” of non-parametric 
tests is that they are less sensitive than parametric tests and fail to detect differences 
between groups that may actually exist [24]. The fact that although the sample sizes are 
small and the power low, non-parametric tests detected significant differences in six 
studies which were conducted in various geographical locations with heterogeneous 
participants is telling.  
 
5. CONCLUSIONS  
The aim of this study was to conduct a systematic review on available evidence from 
online databases for the homeopathic treatment of PMS using The Checklist for 
Measuring Study Quality and Quality Assessment Tool for Studies of Diverse Designs.  
 
Database searches were conducted using the predetermined search terms related to 
homeopathy and PMS. From these searches 63 articles were identified and screened to 
determine whether they could be included in the review. Only seven articles met the 
inclusion criteria to be included in this review. The CMSQ was used to evaluate the 
three RCTs while the rest of the study designs were evaluated using the QATSDD. 
Articles 1,4,6 and 7 ranked “Good”, Articles 2 and 4 ranked “Fair” and Article 5 ranked 
“Poor” using their respective evaluation tools. Article 1 was a good quality article which 
did not support the hypothesis that homeopathy is effective in the treatment of PMS 
however the statistical tests conducted to support the conclusion were incomplete. 
Articles 2 and 5 used incorrect statistical tests and had to be discounted. Of the 
remaining four articles one article ranked “Fair” and three articles ranked “Good”.  
 
From the remaining articles only one (Article 3) was a RCT. This is important as EBM 
uses RCTs as the “gold standard” for research and as such the remaining case studies 
tend to provide little value towards this review especially since the sample sizes were 
small and power of the studies were low. As a result these studies cannot be used to 
support the use of homeopathic treatment for PMS.  
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In conclusion, the outcomes of this study indicate that the current available evidence on 
the therapeutic effects of the homeopathic treatment of PMS cannot contribute to 
Evidence Based Medicine.  
 
5.1 Benefits of this review 
This review has been beneficial for the following reasons: 
 It reviews the quality of homeopathic research being conducted. 
 It provides researchers with recommendations in order to improve further 
research. 
 By including both published and grey literature it allows an unbiased review of 
the best available evidence. 
 
5.2 Limitations 
The reviewer has acknowledged the following limitations while conducting this review: 
 Only studies written in English were included for review 
 Not all articles were available electronically, although electronic records of the 
article were available.  
 
5.3 Recommendations 
For future reviews the following recommendations can be considered: 
 Literature available in other languages may be included 
 Articles available in hard-copy should be included in order to evaluate all 
available evidence.   
 
Further recommendations for conducting studies which evaluate the efficacy of the 
homeopathic treatment on PMS include the following: 
 The power of the study needs to be calculated prior to executing the study as 
sample sizes can be determined by the power which researchers would like to 
achieve.  
 Studies conducted in future should not only include inter-group and intra-group 
analyses but should also include analyses comparing the outcomes of each 
participant as the heterogeneity of the participants could obscure results.  
 Larger sample groups need to be used in future to ensure that the sample is a 
good representation of the population 
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 Participants from both groups (active intervention and control) need to be 
recruited from the same population over the same period of time.  
 External validity of studies should be considered when designing the study’s 
methodology.  
 
6. REFERENCES 
 
1. Chin, L. N. & Nambiar, S., 2017. Management of premenstrual syndrome. 
Obstetrics, Gynaecology & Reproductive Medicine, 27(1), pp. 1-6. 
2. Direkvand-Moghadam, A., Sayehmiri, K., Delpisheh, A. & Kaikhavandi, S., 2014. 
Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-
Analysis Study. Journal of Clinical & Diagnostic Research, 8(2), pp. 106-109. 
3. Ghani, S. & Parveen, T., 2016. Frequency of dysmenorrhea and premenstrual 
syndrome, its impact on quality of life and management approach among medical 
university students. Pakistan Journal of Surgery, 32(2), pp. 104-110. 
4. Guler, O. T. et al., 2015. Validation of Turkish version of Premenstrual Symptoms 
Impact Survey (PMSIS) for assessing status of premenstrual syndrome in 
women of reproductive age. Anatolian Journal of Psychiatry, 16(3), pp. 205-211. 
5. Walsh, S., Ismaili, E., Naheed, B. & O'Brein, S., 2015. Diagnosis, 
pathophysiology and management of premenstrual syndrome. The Obstetrician 
& Gynaecologist, 17(1), pp. 99-104. 
6. Dantas, F. & Rampes, F., 2000. Do homeopathic medicines provoke adverse 
effects? A systematic review. British Homeopathic Journal, 89(1), pp. S35- S38. 
7. Mullin, G., 2011. Homeopathy Origins and Therapeutic Principles. In: Integrative 
Gastroenterology. New York: Oxford University Press, pp. 182-189. 
8. Stevinson, C. & Ernst, E., 2001. Complementary/ alternative therapies for 
premenstrual syndrome: A systematic review of randomized control trials. 
American Journal of Obstetrics and Gynaecology, 185(1), pp. 227-235. 
9. Downs, S. H. & Black, N., 1998. The feasibility of creating a checklist for the 
assessment of the methodological quality both of randomised and non- 
randomised studies of health care interventions. Journal of Epidemiology and 
Community health, Volume 52, pp. 337-384. 
6 
 
10. Sirriyeh, R., Lawton, R., Gardner, P. & Armitage, G., 2012. Reviewing studies 
with diverse designs: the development and evaluation of a new tool. Journal of 
Evaluation in Clinical Practice, 18(4), pp. 746-752. 
11. National Collaborating Centre for Methods and Tools, 2016. Quality Checklist for 
Health Care Intervention Studies. [Online] Available 
at:http://www.nccmt.ca/resources/search/9 
[Accessed 18 March 2017]. 
12. Baxter, R., Taylor, N., Kellar, I. & Lawton, R., 2016. What methods are used to 
apply positive deviance within healthcare organisations? A systematic review. 
BMJ Quality & Safety, 25(3), pp. 190-201. 
13. Harrison, R. et al., 2014. The contribution of nurses to incident disclosure: A 
narrative review. International Journal of Nursing Studies, 51(2), pp. 334-345. 
14. Laister, C., 2008. The efficacy of the homoeopathic similimum in the treatment of 
premenstrual syndrome (PMS). Durban University of Technology: Thesis. 
15. Yakir, M. et al., 2001. Effects of homeopathic treatment in women with 
premenstrual syndrome: a pilot study.. British Homoeopathic Journal, 90(3), pp. 
148-153. 
16. Woodcock, G., 1998. A comparitive study of the effects of Vitex agnus castus 
upon premenstrual syndrome in a mother tincture preparation and a 3X 
homoeopathic preparation. Technikon Witswatersrand: Thesis. 
17. Danno, K., Colas, A., Terzan, L. & Bordet, M.-F., 2012. Homeopathic treatment 
of premenstrual syndrome: a case series. Homeopathy, 102(2013), pp. 59-65. 
18. Komar, T., Peck, K., Torline, J. & Deroukakis, M., 2006. A Qualitative Study to 
Determine the Efficacy of the Homeopathic Similimum in the Treatment of 
Premenstrual Syndrome. American Journal of Homeopathic Medicine , 99(3), pp. 
196-204. 
19. Mudzanani, M. L., 2011. Case studies on the effect of the homoeopathic 
similimum in black females with premenstrual syndrome. Thesis: University of 
Johannesburg. 
20. Patel, R., 2010. The effect of the homeopathic simillimum on white females 
suffering with symptoms of premenstrual syndrome using ten case studies. 
Thesis: University of Johannesburg. 
21. Stark, P. B., 2015. Hypothesis Testing: Does Chance explain the Results?. 
[Online]  
7 
 
Available at: http://www.stat.berkeley.edu/~stark/SticiGui/Text/testing.htm 
[Accessed 27 July 2017]. 
22. Effect Size FAQs, 2010. How do I calculate statistical power. [Online] Available 
at: https://effectsizefaq.com/category/statistical-power/ [Accessed 27 July 2017]. 
23. Freeman, L. W., 2008. Homeopathy: Like Cures Like. In: Mosby's 
Complementary & Alternative Medicine. Missouri: Elsevier Health Sciences, pp. 
347-364. 
24. Pallant, J., 2013. Statistical Techniques to Compare Groups. In: SPSS Survival 
Manual. New York: McGraw-Hill, pp. 211-329. 
 
 
 
 
 
